Global Avelumab Market Growth 2025-2031

December 2025 | 77 pages | ID: GD208A200B4EN
LP Information

Abstracts

The global Avelumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Avelumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Avelumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Avelumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Avelumab players cover Merck, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Avelumab Industry Forecast” looks at past sales and reviews total world Avelumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Avelumab sales for 2025 through 2031. With Avelumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Avelumab industry.

This Insight Report provides a comprehensive analysis of the global Avelumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Avelumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Avelumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Avelumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Avelumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Avelumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• By Usage
• By Specifications

Segmentation by Application:

• Merkel-cell Carcinoma
• Non-small Cell Lung Carcinoma (NSCLC)
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Avelumab market?

What factors are driving Avelumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Avelumab market opportunities vary by end market size?

How does Avelumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Avelumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Avelumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Avelumab by Country/Region, 2020, 2024 & 2031
2.2 Avelumab Segment by Type
  2.2.1 By Usage
  2.2.2 By Specifications
2.3 Avelumab Sales by Type
  2.3.1 Global Avelumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Avelumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Avelumab Sale Price by Type (2020-2025)
2.4 Avelumab Segment by Application
  2.4.1 Merkel-cell Carcinoma
  2.4.2 Non-small Cell Lung Carcinoma (NSCLC)
  2.4.3 Others
2.5 Avelumab Sales by Application
  2.5.1 Global Avelumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Avelumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Avelumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Avelumab Breakdown Data by Company
  3.1.1 Global Avelumab Annual Sales by Company (2020-2025)
  3.1.2 Global Avelumab Sales Market Share by Company (2020-2025)
3.2 Global Avelumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Avelumab Revenue by Company (2020-2025)
  3.2.2 Global Avelumab Revenue Market Share by Company (2020-2025)
3.3 Global Avelumab Sale Price by Company
3.4 Key Manufacturers Avelumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Avelumab Product Location Distribution
  3.4.2 Players Avelumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR AVELUMAB BY GEOGRAPHIC REGION

4.1 World Historic Avelumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Avelumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Avelumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Avelumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Avelumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Avelumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Avelumab Sales Growth
4.4 APAC Avelumab Sales Growth
4.5 Europe Avelumab Sales Growth
4.6 Middle East & Africa Avelumab Sales Growth

5 AMERICAS

5.1 Americas Avelumab Sales by Country
  5.1.1 Americas Avelumab Sales by Country (2020-2025)
  5.1.2 Americas Avelumab Revenue by Country (2020-2025)
5.2 Americas Avelumab Sales by Type (2020-2025)
5.3 Americas Avelumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Avelumab Sales by Region
  6.1.1 APAC Avelumab Sales by Region (2020-2025)
  6.1.2 APAC Avelumab Revenue by Region (2020-2025)
6.2 APAC Avelumab Sales by Type (2020-2025)
6.3 APAC Avelumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Avelumab by Country
  7.1.1 Europe Avelumab Sales by Country (2020-2025)
  7.1.2 Europe Avelumab Revenue by Country (2020-2025)
7.2 Europe Avelumab Sales by Type (2020-2025)
7.3 Europe Avelumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Avelumab by Country
  8.1.1 Middle East & Africa Avelumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Avelumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Avelumab Sales by Type (2020-2025)
8.3 Middle East & Africa Avelumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Avelumab
10.3 Manufacturing Process Analysis of Avelumab
10.4 Industry Chain Structure of Avelumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Avelumab Distributors
11.3 Avelumab Customer

12 WORLD FORECAST REVIEW FOR AVELUMAB BY GEOGRAPHIC REGION

12.1 Global Avelumab Market Size Forecast by Region
  12.1.1 Global Avelumab Forecast by Region (2026-2031)
  12.1.2 Global Avelumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Avelumab Forecast by Type (2026-2031)
12.7 Global Avelumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Avelumab Product Portfolios and Specifications
  13.1.3 Merck Avelumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Avelumab Product Portfolios and Specifications
  13.2.3 Pfizer Avelumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Avelumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Avelumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of By Usage
Table 4. Major Players of By Specifications
Table 5. Global Avelumab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Avelumab Sales Market Share by Type (2020-2025)
Table 7. Global Avelumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Avelumab Revenue Market Share by Type (2020-2025)
Table 9. Global Avelumab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Avelumab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Avelumab Sale Market Share by Application (2020-2025)
Table 12. Global Avelumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Avelumab Revenue Market Share by Application (2020-2025)
Table 14. Global Avelumab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Avelumab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Avelumab Sales Market Share by Company (2020-2025)
Table 17. Global Avelumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Avelumab Revenue Market Share by Company (2020-2025)
Table 19. Global Avelumab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Avelumab Producing Area Distribution and Sales Area
Table 21. Players Avelumab Products Offered
Table 22. Avelumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Avelumab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Avelumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Avelumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Avelumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Avelumab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Avelumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Avelumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Avelumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Avelumab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Avelumab Sales Market Share by Country (2020-2025)
Table 35. Americas Avelumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Avelumab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Avelumab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Avelumab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Avelumab Sales Market Share by Region (2020-2025)
Table 40. APAC Avelumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Avelumab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Avelumab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Avelumab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Avelumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Avelumab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Avelumab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Avelumab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Avelumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Avelumab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Avelumab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Avelumab
Table 52. Key Market Challenges & Risks of Avelumab
Table 53. Key Industry Trends of Avelumab
Table 54. Avelumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Avelumab Distributors List
Table 57. Avelumab Customer List
Table 58. Global Avelumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Avelumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Avelumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Avelumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Avelumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Avelumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Avelumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Avelumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Avelumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Avelumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Avelumab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Avelumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Avelumab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Avelumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Avelumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Avelumab Product Portfolios and Specifications
Table 74. Merck Avelumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Pfizer Basic Information, Avelumab Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Avelumab Product Portfolios and Specifications
Table 79. Pfizer Avelumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Avelumab
Figure 2. Avelumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avelumab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Avelumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Avelumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Avelumab Sales Market Share by Country/Region (2024)
Figure 10. Avelumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of By Usage
Figure 12. Product Picture of By Specifications
Figure 13. Global Avelumab Sales Market Share by Type in 2025
Figure 14. Global Avelumab Revenue Market Share by Type (2020-2025)
Figure 15. Avelumab Consumed in Merkel-cell Carcinoma
Figure 16. Global Avelumab Market: Merkel-cell Carcinoma (2020-2025) & (K Pcs)
Figure 17. Avelumab Consumed in Non-small Cell Lung Carcinoma (NSCLC)
Figure 18. Global Avelumab Market: Non-small Cell Lung Carcinoma (NSCLC) (2020-2025) & (K Pcs)
Figure 19. Avelumab Consumed in Others
Figure 20. Global Avelumab Market: Others (2020-2025) & (K Pcs)
Figure 21. Global Avelumab Sale Market Share by Application (2024)
Figure 22. Global Avelumab Revenue Market Share by Application in 2025
Figure 23. Avelumab Sales by Company in 2025 (K Pcs)
Figure 24. Global Avelumab Sales Market Share by Company in 2025
Figure 25. Avelumab Revenue by Company in 2025 ($ millions)
Figure 26. Global Avelumab Revenue Market Share by Company in 2025
Figure 27. Global Avelumab Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Avelumab Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Avelumab Sales 2020-2025 (K Pcs)
Figure 30. Americas Avelumab Revenue 2020-2025 ($ millions)
Figure 31. APAC Avelumab Sales 2020-2025 (K Pcs)
Figure 32. APAC Avelumab Revenue 2020-2025 ($ millions)
Figure 33. Europe Avelumab Sales 2020-2025 (K Pcs)
Figure 34. Europe Avelumab Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Avelumab Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Avelumab Revenue 2020-2025 ($ millions)
Figure 37. Americas Avelumab Sales Market Share by Country in 2025
Figure 38. Americas Avelumab Revenue Market Share by Country (2020-2025)
Figure 39. Americas Avelumab Sales Market Share by Type (2020-2025)
Figure 40. Americas Avelumab Sales Market Share by Application (2020-2025)
Figure 41. United States Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Avelumab Sales Market Share by Region in 2025
Figure 46. APAC Avelumab Revenue Market Share by Region (2020-2025)
Figure 47. APAC Avelumab Sales Market Share by Type (2020-2025)
Figure 48. APAC Avelumab Sales Market Share by Application (2020-2025)
Figure 49. China Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 53. India Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Avelumab Sales Market Share by Country in 2025
Figure 57. Europe Avelumab Revenue Market Share by Country (2020-2025)
Figure 58. Europe Avelumab Sales Market Share by Type (2020-2025)
Figure 59. Europe Avelumab Sales Market Share by Application (2020-2025)
Figure 60. Germany Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 61. France Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Avelumab Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Avelumab Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Avelumab Sales Market Share by Application (2020-2025)
Figure 68. Egypt Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Avelumab Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Avelumab in 2025
Figure 74. Manufacturing Process Analysis of Avelumab
Figure 75. Industry Chain Structure of Avelumab
Figure 76. Channels of Distribution
Figure 77. Global Avelumab Sales Market Forecast by Region (2026-2031)
Figure 78. Global Avelumab Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Avelumab Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Avelumab Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Avelumab Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Avelumab Revenue Market Share Forecast by Application (2026-2031)